Carefirst of Maryland, Inc., et al. v. Johnson & Johnson, et al.
Case Number:
2:23-cv-00629
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Dechert LLP
- Glasser & Glasser
- Hagens Berman
- Lawrence Law LLC
- Lowey Dannenberg
- Nelson Mullins
- Patterson Belknap
- Radice Law Firm
Companies
Sectors & Industries:
-
November 06, 2025
CareFirst Urges Ban On J&J Character Talk At Stelara Trial
Health insurer CareFirst is asking a Virginia federal judge to bar Johnson & Johnson from promoting its "good character" to a jury that will weigh class claims of anticompetitive conduct and patent fraud to extend market protection on the blockbuster autoimmune drug Stelara.
-
March 06, 2024
J&J Seeks Exit From Suit Over Stelara Exclusivity
Johnson & Johnson told a Virginia federal court Tuesday it shouldn't have to face a proposed class action claiming it has been trying to stifle competition in the market for the immunosuppressive drug Stelara, saying there was no "scheme" to enforce its patents as the suit alleges.
-
December 08, 2023
J&J Hit With Suit Over Stelara Exclusivity
A group of Blue Cross and Blue Shield licensees has filed a lawsuit in Virginia federal court claiming Johnson & Johnson has been trying to stifle competition in the market for the immunosuppressive drug Stelara, saying it defrauded federal patent officials.